See every side of every news story
Published loading...Updated

Illinois Reaches $23M Settlement with Eight Pharma Firms over Opioid Crisis

ALABAMA, JUL 11 – Alabama will receive $11.7 million from an $720 million nationwide opioid settlement requiring drug makers to limit opioid marketing and monitor suspicious orders.

  • Attorney General Kwame Raoul announced a $720 million settlement with eight pharmaceutical companies impacting nine states, including Illinois.
  • The settlements resulted from investigations into deceptive practices that increased opioid prescriptions and fueled the nationwide opioid crisis.
  • Illinois could receive over $23 million from companies like Indivior, Sun, Alvogen, and Zydus, with varying payment schedules and restrictions on opioid marketing.
  • As part of the agreement, seven companies are barred from marketing opioids and are restricted from producing or selling any opioid products that exceed 40 milligrams of oxycodone per dosage unit, while Indivior has committed to a 10-year halt on manufacturing opioid medications.
  • The settlement enables continued efforts to hold opioid manufacturers accountable and aims to address the opioid crisis through financial penalties and regulatory measures.
Insights by Ground AI
Does this summary seem wrong?

15 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center
50% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

alabamaag.gov broke the news in on Friday, July 11, 2025.
Sources are mostly out of (0)